Anskar Yu-Hung Leung

17PUBLICATIONS
75CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical bacteriologyNanomedicineHaematological tumoursGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 06, 2026
Quizartinib and omacetaxine mepesuccinate combination therapy in FLT3-ITD AML: a phase II trial.

Li-Chuan Zheng, Kelvin K W Wong, Stephen S Y Lam

|Nov 17, 2025
Early measurable residual disease detection post-haematopoietic stem cell transplantation in acute myeloid leukaemia.

Sze P Tsui, Stephen S Y Lam, Chun H Au

|Jul 07, 2025
Hypomethylating agent versus venetoclax combination: an electronic health records-based target trial emulation among Asian elderly patients with newly diagnosed acute myeloid leukaemia in Hong Kong.

Qiwen Fang, Chi Yeung Fung, Jiaqi Wang

|May 21, 2025
Mechanism of Initial Favorable Response to Decitabine in TP53-Mutated MDS/AML and Potential Mechanisms of Subsequent Relapse.

Nelson K L Ng, Stephen S Y Lam, Lichuan Zheng

|Mar 17, 2024
Application of droplet digital PCR in minimal residual disease monitoring of rare fusion transcripts and mutations in haematological malignancies.

Beca B K Ip, Anthony T C Wong, Janet Hei Yin Law

|Dec 06, 2023
Distinct karyotypic and mutational landscape in trisomy AML.

Stephen S Y Lam, Sze P Tsui, C Y Fung

Pageof 3

Frequent Collaborators

5 joint publications

Stephen S Y Lam

3 joint publications

Asif Javed

3 joint publications

Edmond S K Ma

3 joint publications

Chi Wai Eric So